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to investigate the degree of agreement of lung ultrasonography and
computed tomography (CT) results in diagnosing certain main char-
acteristics of ALI/ARDS in rats.
METHODS Thirty male Sprague-Dawley rats were randomized into
three groups, each group have ten rats. ALI/ARDS was induced in the
rats of the two experimental groups by intratracheal instillation of LPS
at different concentration (2 mg/ml LPS at 3 mg/kg, 4 mg/ml LPS at 6
mg/kg). The control group were instilled with the same volume of
isotonic saline solution. After two hours, lung ultrasound was per-
formed. Then, three rats in each group immediately underwent chest
micro-PET/CT scan. Cross table analyses and kappa statistics were
used to determine the levels of agreement between LUS and CT
assessments for the main characteristics of ALI/ARDS in rats.
RESULTS Most of the healthy rats presented A pattern; however, B
lines appeared when we instilled NS/LPS to the trachea, the LPS
groups showed more B lines than the NS group. One rat in the 4 mg/ml
LPS group presented a consolidation sign. The agreements between
the LUS and the CT in detecting the main characteristics of ALI/ARDS
in rat lungs were strong (k¼0.785). Additionally, a signiﬁcant corre-
lation was found between LUS and CT imaging in the detection of the
main characteristics of ALI/ARDS (r¼0.79. p<0.01).
CONCLUSIONS In an experimental rat model of ALI/ARDS, the data
showed that LUS can detect the main characteristics of ALI/ARDS with
high agreement with micro PET/CT scanning results, suggesting that
LUS is a good alternative for the diagnosis of ALI/ARDS in rats.GW26-e0775
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OBJECTIVES Pulmonary embolism is a common fatal emergency, the
misdiagnosis rate and missed diagnosis is high, a variety of reasons
can cause or induce pulmonary embolism, however, the relationship
between hypoalbuminemia and pulmonary embolism is still a lack of
research, this article aims to explore hypoalbuminemia complicated
by pulmonary embolism related mechanism, so as to provide the basis
for clinical and basic research.
METHODS In recent years we caused by three different causes were
treated with hypoalbuminemia patients complicated with pulmonary
embolism were analyzed retrospectively and related literatures were
reviewed.
RESULTS Blood coagulation and ﬁbrinolysis imbalance, platelet ag-
gregation, increased blood viscosity, may be the result of pulmonary
embolism hypoalbuminemia mechanism.
CONCLUSIONS Emphasis on hypoalbuminemia merger risk factors of
pulmonary embolism, is very important for early diagnosis and
improve the prognosis.GW26-e3897
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OBJECTIVES To evaluate the efﬁcacy of thrombolytic therapy with
reteplase and investigate the clinical value of detecting plasma lactate
and N-terminal pro-brain natriuretic peptide (NT-proBNP) changes in
patients with acute pulmonary embolism (APE).
METHODS This was a retrospective study at the Cardiology depart-
ment of the hospital. All patients with a diagnosis of PE established
by lung scan or spiral computed tomography (CT) and conﬁrmed
by pulmonary angiography if necessary. From September 2011 to
September 2014, a total of 184 patients were diagnosed with PE. Of
these patients, 56 patients complied with the requirements for
thrombolytic therapy were included in this analysis. they were treated
with reteplase thrombolytic therapy. Plasma lactate, NT-proBNP and
cardiac troponin T(cTnT) levels were monitored before and up to ６h
after thrombolytic therapy. Echocardiography evaluation, multi-
detector row CT and ventilation-perfusion scintigraphy were repeated
after 12-24 hours to reevaluate perfusion status.RESULTS 49(87.5%) patients exhibited signiﬁcant reperfu-
sion.7(12.5%) patients exhibited no signiﬁcant reperfusion, 4(7.1%)
patients died during their hospital stay. Plasma lactate, NT-proBNP
and mean pulmonary arterial pressure decreased signiﬁcantly in
all of patients of reperfusion group (7.142.71 mmol/L to 2.040.56
mmol/L; 8672.4201.7 pg/ml to 1559.8  23.5 pg/ml; 52.8217.34
mmHg to 38.1312.32 mmHg, P<0. 01). Plasma lactate and NT-
proBNP levels decreased has a positive correlation with pulmonary
arterial pressure, RV/LV ratio (r 0.68, 0.62, 0.57, P<0.01). No sig-
niﬁcant variation was observed in cTnT levels. As compared
with pre-treatment, there was no signiﬁcant improvement in
levels of plasma lactate and NT-proBNP in negative angiographic
reperfusion patients. 7 cases (7/56,12.5%) in these patients with
bleeding, 2 cases nasal bleeding，1 case bleeding gums, 1 case
hemorrhoids bleeding, 1 case hemoptysis and macroscopic hema-
turia in 2 cases. No death of fatal bleeding reason in the process of
hospital stay.
CONCLUSIONS Thrombolytic therapy with reteplase is effective and
safe for acute pulmonary embolism. Serial measurements of plasma
lactate and NT-proBNP could be useful as a tracking tool to assess the
success or failure of the thrombolytic treatment.KIDNEY DISEASE
GW26-e0678
The risk of preexisted microalbuminuria for contrast-induced acute kidney
injury after scheduled coronary angiography among patients with a
preserved renal function
Haoyu Meng, Yingming Zhao, Min Zhang, Xin Lu, Chunjian Li,
Liansheng Wang, Zhijian Yang
First Afﬁliated Hospital of Naning Medical University, Jiangsu Province
Hospital
OBJECTIVES To investigate the association between preexisted
microalbuminuria and contrast-induced acute kidney injury (AKI)
after coronary angiography among patients with a preserved renal
function.
METHODS 612 consecutive patients with a preserved renal function
undergoing scheduled coronary angiography were stratiﬁed into
microalbuminuria group (107 patients) and normal-albuminuria group
(505 patients) according to the albumin to creatinine ratio (ACR)
levels. Microalbuminuria was deﬁned as ACR in the range of 30-300
mg/g and normal-albuminuria was deﬁned as ACR <30 mg/g.
Contrast-induced AKI was deﬁned as a relative increase in serum
creatinine (SCr) concentration of at least 25% or an absolute increase
in SCr of 0.5 mg/dl within 72 hours after the procedure.
RESULTS The peak increases of SCr in microalbuminuria group were
signiﬁcantly larger than those in normal-albuminuria group (10.6 
12.4mmol/L vs 4.8  8.9mmol/L, P¼0.000), and the incidence of AKI
was signiﬁcantly higher in patients with microalbuminuria than those
with normal-albuminuria (12.1% vs 5.0%, P¼0.005). Multivariable
analysis revealed that there was a strong association between micro-
albuminuria and contrast-induced AKI risk after adjusting for con-
founders (P¼0.005).
CONCLUSIONS Preexisting microalbuminuria is associated with
greater risk for AKI in patients with a preserved renal function who
undergo scheduled coronary angiography.GW26-e5379
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OBJECTIVES To investigate the effects of short-term peri-procedural
double-dose (vs usual-dose) atorvastatin (both the most common
